Company: LRHC
Filing Date: 2025-11-24
Form Type: PRE 14C
Source: 0001213900-25-113797
Chunk: 2

Company: La Rosa Holdings Corp.
Filing Date: 2025-11-24
Form: PRE 14C
Chunk 2
---
 (each, a “Reverse Stock Split”) to be effected at any                    
 time or times within one (1) year from the date of such approval, with such timing and ratios to be determined in the discretion of 
 the Board of Directors for all stockholders as of the date of the effectiveness of the Reverse Stock Split, with the right to       
 abandon the Reverse Stock Split, if the Board of Directors, in its discretion, determines that the Reverse Stock Split is no longer 
 in the best interests of the Company or its stockholders, and approval of an amendment to the Company’s Amended and Restated        
 Articles of Incorporation with respect to such Reverse Stock Split (the “Reverse Stock Split                                        
 Amendment”).                                                                                                                        |

The Majority Stockholders’
consent constitutes the only stockholder approval required under the NRS, Nasdaq Listing Rules 5635(b) and 5635(d) (the “Nasdaq 20% Rule”) (with respect to the first Corporate Action listed above), our Amended and Restated Articles of Incorporation, and
our Bylaws, to approve the Corporate Actions. Our Board of Directors is not soliciting your consent or your proxy in connection with these
Corporate Actions and neither consents nor proxies are being requested from stockholders.

The actions taken by written
consent of the Majority Stockholders will not become effective until the date that is twenty (20) calendar days after this Information
Statement is first mailed or otherwise delivered to holders of our Common Stock as of the Record Date.

| By Order of the Board of Directors,  |
| Joseph La Rosa                       |
| Chief Executive Officer and Chairman |
| [*], 2025                            |

<div align='center'>TABLE OF CONTENTS</div>

| GENERAL INFORMATION                                                                                                                                                            |     |  1 |
| Background                                                                                                                                                                     |     |  1 |
| ACTIONS TAKEN                                                                                                                                                                  |     |  3 |
| 1. APPROVAL OF THE ISSUANCE OF ALL NOTES AND CONVERSION SHARES IN EXCESS OF 19.99% OF THE COMPANY’S ISSUED AND OUTSTANDING COMMON STOCK AT A PRICE LESS THAN THE MINIMUM PRICE |     |  3 |
| 2. APPROVAL OF THE SERIES X AMENDMENT                                                                                                                                          |     |  8 |
| 3. APPROVAL OF THE REVERSE STOCK SPLIT AMENDMENT AND AUTHORIZATION TO THE BOARD OF DIRECTORS TO EFFECT THE REVERSE STOCK SPLIT AT THEIR DISCRETION                             |     |